Home›People›Tomas Kiselak
TK

Tomas Kiselak

Director and 10% owner at Korsana Biosciences. Also a director at Interius BioTherapeutics and Zenas BioPharma.

DirectorPublic companyRoles at 2 startups
Updated Nov 9, 2026·Latest SEC filing Sep 10, 2026·Suggest an edit

About Tomas Kiselak

Tomas Kiselak is a director and 10% owner at Korsana Biosciences.

Form D filings name Tomas Kiselak as a director at Interius BioTherapeutics and Zenas BioPharma.

Tomas Kiselak reports to the SEC as a director or major shareholder of 10 public companies, including Apogee Therapeutics (APGE), Crescent Biopharma (CBIO) and Viridian Therapeutics (VRDN).

Tomas Kiselak first appears on SEC filings in 2020.

Experience

This experience comes from SEC filings. The years are when the filings name Tomas Kiselak in the role, so the role may have started earlier or lasted longer.

Korsana Biosciences, Inc.
Director and 10% owner
2026 · Public company (KRSA)
Apogee Therapeutics, Inc.
Director
2023 – 2026 · Public company (APGE)
Crescent Biopharma, Inc.
Director and 10% owner
2025 – 2026 · Public company (CBIO)
Viridian Therapeutics, Inc.
Director
2020 – 2026 · Public company (VRDN)
Oruka Therapeutics, Inc.
Director and 10% owner
2024 – 2026 · Public company (ORKA)
Spyre Therapeutics, Inc.
Director and 10% owner
2023 – 2026 · Public company (SYRE)
Jade Biosciences, Inc.
Director and 10% owner
2025 – 2026 · Public company (JBIO)
Zenas BioPharma, Inc.
Director and 10% owner
2022 – 2026 · Public company (ZBIO)
Damora Therapeutics, Inc.
10% owner
2025 – 2026 · Public company (DMRA)
Dianthus Therapeutics, Inc.
Director and 10% owner
2023 – 2024 · Public company (DNTH)
Interius BioTherapeutics, Inc.
Director
2021 – 2024 · Philadelphia, PA

Key Colleagues at Startups

The people Tomas Kiselak works with at each company, as listed on that company's latest Form D.

Interius BioTherapeutics, Inc. · Form D, Jun 3, 2024
LM
Leon Moulder
Director
BC
Bihua Chen
Director
DM
Dora Mitchell
Executive officer
PD
Philip Johnson, M.D.
President and Chief Executive Officer, director
Zenas BioPharma, Inc. · Form D, May 14, 2024
PE
PA
JF
Joseph Farmer
PRESIDENT and CHIEF OPERATING OFFICER
LJ
Leon Moulder, Jr.
Executive officer and director
JN
Jake Nunn
Director
TX
Tim Xiao
Director
JF
Jennifer Fox
Executive officer
JB
James Boylan
Director
TF
Tanya Fischer
Executive officer
JO
John Orloff
Director
HL
Hongbo Lu
Director

Sources

  1. SECInterius BioTherapeutics, Inc. Form D, filed Jun 3, 2024
  2. SECZenas BioPharma, Inc. Form D, filed May 14, 2024
  3. SECForms 3, 4 and 5 filed by Tomas Kiselak (SEC filer 1830177)